Boston Scientific Launches Next Generation Of Cardiac Mapping For The FARAPULSE Pulsed Field Ablation System
Portfolio Pulse from Benzinga Newsdesk
Boston Scientific has received FDA approval for its new FARAWAVE NAV Ablation Catheter and FARAVIEW Software, enhancing its FARAPULSE Pulsed Field Ablation System for treating atrial fibrillation.
October 18, 2024 | 8:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Boston Scientific received FDA approval for its FARAWAVE NAV Ablation Catheter and FARAVIEW Software, enhancing its cardiac ablation technology.
The FDA approval and clearance of new products are likely to positively impact Boston Scientific's stock as it enhances their product offerings in the cardiac ablation market, potentially increasing sales and market share.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100